FAM
IMCR icon

Fred Alger Management’s Immunocore IMCR Stock Holding History

Fred Alger Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,479
Closed -$616K – 451
2024
Q1 		$616K Buy
9,479
+3,272
+53% +$225K ﹤0.01% 385
2023
Q4 		$424K Buy
6,207
+2,002
+48% +$104K ﹤0.01% 403
2023
Q3 		$218K Sell
4,205
-2,359
-36% -$140K ﹤0.01% 404
2023
Q2 		$394K Buy
6,564
+1,517
+30% +$86.6K ﹤0.01% 407
2023
Q1 		$250K Sell
5,047
-3,312
-40% -$186K ﹤0.01% 420
2022
Q4 		$477K Buy
8,359
+382
+5% +$21.5K ﹤0.01% 403
2022
Q3 		$374K Buy
+7,977
New +$380K ﹤0.01% 409

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fred Alger Management's IMCR Position: Q2 2024 in Review

Fred Alger Management sold out of Immunocore (IMCR) in Q2 2024, closing a stake of 9,479 shares — an estimated $616K sold.

Fred Alger Management first reported a position in IMCR in Q3 2022 and held it in 7 quarters. The position peaked at $616K in Q1 2024. 138 funds tracked by Wall St. Rank hold IMCR as of Q2 2024.

  • Fred Alger Management reported no remaining Immunocore position as of Q2 2024 after selling out during the quarter.
  • Fred Alger Management sold 9,479 Immunocore shares in Q2 2024, an estimated $616K.
  • Fred Alger Management first reported a position in Immunocore in Q3 2022 and held it in 7 quarters.
  • Fred Alger Management's Immunocore position peaked at $616K in Q1 2024.
  • 138 funds tracked by Wall St. Rank held Immunocore as of Q2 2024.

Based on Fred Alger Management's 13F filing for Q2 2024, filed 14 Aug 2024.